Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis

被引:82
作者
Bernasconi, S
Cinque, P
Peri, G
Sozzani, S
Crociati, A
Torri, W
Vicenzi, E
Vago, L
Lazzarin, A
Poli, G
Mantovani, A
机构
[1] IST RIC FARMACOL MARIO NEGRI,DIBIT,I-20157 MILAN,ITALY
[2] SAN RAFFAELE SCI INST,DIV INFECT DIS,I-20132 MILAN,ITALY
[3] L SACRO INST MED SCI,MILAN,ITALY
[4] UNIV BRESCIA,DEPT BIOTECHNOL,SECT PATHOL & IMMUNOL,BRESCIA,ITALY
关键词
D O I
10.1093/infdis/174.5.1098
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The CC chemokine monocyte chemotactic protein-1 (MCP-1) was markedly elevated in the cerebrospinal fluid (CSF) of human immunodeficiency virus (HIV)-infected patients with cytomegalovirus (CMV) encephalitis. The MCP-1 CSF levels in CMV encephalitis were markedly higher than those in the CSF of HIV-infected patients with or without unrelated neurologic diseases, including progressive multifocal leukoencephalopathy, cryptococcal meningitis, toxoplasmic encephalitis, and primary lymphoma. Interleukin-8, RANTES, macrophage inflammatory protein (MIP)-1 alpha, and MIP-1 beta were not substantially increased in the CSF of CMV encephalitis patients. High levels of MCP-1 may underlie monocyte recruitment and tissue damage in CMV encephalitis and may represent a rapid and useful tool in the diagnostic armamentarium for neurologic disorders associated with HIV infection.
引用
收藏
页码:1098 / 1101
页数:4
相关论文
共 17 条
[1]  
ANDERS KH, 1986, AM J PATHOL, V124, P537
[2]  
BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P99
[3]  
BOOSS J, 1989, AM J PATHOL, V134, P71
[4]  
Breiman L., 1984, Classification and Regression Trees, DOI DOI 10.2307/2530946
[5]   INFECTIONS WITH CRYPTOCOCCUS-NEOFORMANS IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
CHUCK, SL ;
SANDE, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (12) :794-799
[6]   CYTOMEGALOVIRUS-INFECTION OF THE CENTRAL-NERVOUS-SYSTEM IN PATIENTS WITH AIDS - DIAGNOSIS BY DNA AMPLIFICATION FROM CEREBROSPINAL-FLUID [J].
CINQUE, P ;
VAGO, L ;
BRYTTING, M ;
CASTAGNA, A ;
ACCORDINI, A ;
SUNDQVIST, VA ;
ZANCHETTA, N ;
MONFORTE, AD ;
WAHREN, B ;
LAZZARIN, A ;
LINDE, A .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (06) :1408-1411
[7]   EVALUATION OF THE POLICY OF EMPIRIC TREATMENT OF SUSPECTED TOXOPLASMA ENCEPHALITIS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
COHN, JA ;
MCMEEKING, A ;
COHEN, W ;
JACOBS, J ;
HOLZMAN, RS .
AMERICAN JOURNAL OF MEDICINE, 1989, 86 (05) :521-527
[8]  
GAO JL, 1994, J BIOL CHEM, V269, P28539
[9]   RAPID DETECTION OF CYTOMEGALOVIRUS DNA IN CEREBROSPINAL-FLUID OF AIDS PATIENTS WITH NEUROLOGIC DISORDERS [J].
GOZLAN, J ;
SALORD, JM ;
ROULLET, E ;
BAUDRIMONT, M ;
CABURET, F ;
PICARD, O ;
MEYOHAS, MC ;
DUVIVIER, C ;
JACOMET, C ;
PETIT, JC .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (06) :1416-1421
[10]   CYTOMEGALOVIRUS INFECTIONS OF THE NERVOUS-SYSTEM IN PATIENTS WITH AIDS [J].
MCCUTCHAN, JA .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (04) :747-754